💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

New Strong Buy Stocks For July 20th

Published 07/19/2017, 10:46 PM
Updated 07/09/2023, 06:31 AM

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Agenus Inc (AGEN): This immuno-oncology (I-O) company has witnessed the Zacks Consensus Estimate for its current year earnings surging 10.2% over the last 30 days.

Agenus Inc. Price and Consensus

Agenus Inc. Price and Consensus | Agenus Inc. Quote

Alcobra Ltd (ADHD): This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings soaring 16.7% over the last 30 days.

Alcobra Ltd. Price and Consensus

Alcobra Ltd. Price and Consensus | Alcobra Ltd. Quote

BOK Financial Corporation (BOKF): This financial holding company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.5% over the last 30 days.

Cellectis SA (CLLS): This company active in the field of genome engineering and genomic surgery has seen the Zacks Consensus Estimate for its current year earnings increasing 2.9% over the last 30 days.

Cellectis S.A. Price and Consensus

Cellectis S.A. Price and Consensus | Cellectis S.A. Quote

Chemours Co (CC): This provider of performance chemicals has witnessed the Zacks Consensus Estimate for its current year earnings improving 4.5% over the last 30 days.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

Want to see all of today's Zacks Strong Buys?

You are welcome to download the full, up-to-the-minute list of 220 Zacks Rank #1 stocks free of charge. There is no better place to start your own stock search. Plus you can also access the full list of must-avoid Zacks Strong Sells and other private research. See the stocks free >>.



Cellectis S.A. (CLLS): Free Stock Analysis Report

Chemours Company (The) (CC): Free Stock Analysis Report

BOK Financial Corporation (BOKF): Free Stock Analysis Report

Agenus Inc. (AGEN): Free Stock Analysis Report

Alcobra Ltd. (ADHD): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.